(Bloomberg) -- Disappointing trial results for Novo Nordisk A/S’s experimental obesity shot capped a volatile year for investors in drug developers vying for a piece of pharma’s hottest market.Most Read from BloombergHo Chi Minh City Opens First Metro Line After Years of DelayReviving a Little-Known Modernist Landmark in BuffaloThe Architects Who Built MiamiNew York’s Congestion Pricing Plan Still Faces Legal HurdlesNew York City’s Historic Preservation Movement Is Having a Midlife CrisisNovo sh
Stocks Mostly Down Pre-Bell Ahead of Holiday-Shortened Trading Week; Asia, Europe Up
The benchmark US stock measures were mostly trending lower before the opening bell Monday, as trader
Top analyst revisits Broadcom stock price target amid December surge
Broadcom shares have added around $250 billion in value this month.
US crypto industry eyes possible day-one Trump executive orders
The cryptocurrency industry is pushing President-elect Donald Trump's team to kick start his promised crypto policy overhaul when he takes office next month with executive orders that would help push tokens mainstream, according to industry officials. Trump plans to issue a flurry of executive orders and directives on everything from immigration to energy on his first day in office on Jan. 20, Reuters reported this month. On the campaign trail, Trump courted crypto cash with promises to be a "crypto president," and the industry wants him to make good on that pledge with executive orders creating a bitcoin stockpile, ensuring the industry can access banking services, and creating a crypto council, the people said.
Volkswagen shares fall as markets struggles to digest unions deal
Volkswagen shares were down 3% in early trade on Monday with analysts citing uncertainty about the automaker's cost-cutting deal with unions and likely headwinds in 2025. It fell short of management's initial ambitions and market expectations, and lacked a sense of urgency, according to Jefferies analyst Philippe Houchois. VW's earnings momentum is also unlikely to improve significantly next year given weak demand in China and potential tariffs after Donald Trump's election, they added.
How investments may fare during Trump 2.0 and Fed easing
U.S. investors are preparing for a swathe of changes in 2025, from tariffs and deregulation to tax policy, that will ripple through markets as President-elect Donald Trump returns to the White House, putting the focus on whether the U.S. economy can continue to outperform. The changing of the guard in Washington has big implications for how stocks, bonds and currencies fare in the new year and may require investors to rejig portfolios. Forecasts call for another buoyant year for stocks, the dollar to maintain its recent strength over the coming months and Treasury yields to march higher.
Stock Market Today: Stocks mixed with Santa Claus boost in focus
Wall Street's 'Santa Claus Rally' has typically boosted stocks by around 1.3% over the final five trading days of the year, as well as the first two of the next.
Money market account rates today, December 23, 2024 (earn up to 5.00% APY)
Compare the best money market account rates available today and find out which banks have the best offers.
Wall Street Expected a Good Year for These 3 Stocks—What Happened?
These three stocks were expected to soar by double digits this year. Instead, they dropped by the same amount. What went wrong?
Is Shiba Inu a Millionaire-Maker Cryptocurrency?
Few assets have demonstrated more millionaire-maker potential than Shiba Inu (CRYPTO: SHIB), a controversial cryptocurrency that soared by 45,278,000% in 2021. Now, Shiba Inu is rising once again. Meme coins, which started in 2013 with the launch of Dogecoin, are less serious cryptocurrencies based on internet jokes.